Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Jul 18;6(7):e005835. doi: 10.1161/JAHA.117.005835

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

Prevalence of baseline characteristics of AF patients with and without valvular heart disease. AF indicates atrial fibrillation; ARISTOTLE, Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation; CAD, coronary artery disease; CI, confidence interval; ENGAGE AF, Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation; Hx, history; M‐H, Mantel–Haenszel; MI, myocardial infarction; RE‐LY, Randomized Evaluation of Long‐Term Anticoagulation Therapy; ROCKET AF, Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation; VHD, valvular heart disease.